Skip to main content

Table 4 Length of stay by SARS-CoV-2, testing, and non-SARS-CoV-2 pathogen status

From: A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19

Admission site and pathogen status

Not tested for SARS-CoV-2

Tested for SARS-CoV-2

SARS-CoV-2 negative

SARS-CoV-2 positive

n

LOS

n

LOS

n

LOS

Hospitala

449,339

4.2 (8.0) [2]

124,618

5.1 (8.9) [3]

17,003

8.6 (11.4) [6]

 Positive for non-SARS-CoV-2 pathogen

52,418

7.1 (11.0) [4]

24,442

8.2 (11.5) [5]

3483

13.7 (15.7) [9]

 Negative for non-SARS-CoV-2 pathogen

396,921

3.9 (7.4) [2]

100,176

4.3 (7.9) [3]

13,566

7.3 (9.6) [5]

 Multiple non-SARS-CoV-2 pathogens

17,871

8.7 (13.2) [5]

9101

10.2 (14.6) [6]

1192

17.5 (16.1) [14]

ICUa

47,629

3.6 (5.9) [2]

21,060

3.8 (6.2) [2]

4076

7.8 (8.5) [5]

  1. Data are expressed as mean (standard deviation) [median] days. P < 0.05 across groups for all outcomes
  2. Note: ICU intensive care unit, LOS length of stay
  3. aOverall hospital and ICU LOS include patients with no specimen collected